Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Artal Group | 3.0M | $52M | 20% | Dec 2023 |
|
| BVF | 1.5M | $26M | 0% | Dec 2023 |
|
| Vivo Capital | 1.1M | $24M | 117% | Mar 2024 |
|
| Aquilo Capital Management | 1.0M | $18M | -20% | Dec 2023 |
|
| Frazier Life Sciences Management | 881k | $15M | 0% | Dec 2023 |
|
| Logos Global Management | 400k | $6.9M | 100% | Dec 2023 |
|
| M28 Capital Management | 364k | $6.3M | 0% | Dec 2023 |
|
| Lynx1 Capital Management | 236k | $4.1M | 0% | Dec 2023 |
|
| Hsbc Holdings | 178k | $3.1M | 0% | Dec 2023 |
|
| Cantor Fitzgerald, L. P. | 147k | $2.5M | -13% | Dec 2023 |
|
| UBS Group | 70k | $1.2M | 1% | Dec 2023 |
|
| Citigroup | 58k | $1.0M | 0% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 49k | $855k | 6% | Dec 2023 |
|
| William Blair $ Company | 26k | $444k | -34% | Dec 2023 |
|
| Citadel Advisors | 22k | $378k | 100% | Dec 2023 |
|
| SG Americas Securities | 6.3k | $110k | 100% | Dec 2023 |
|
| Lazard Asset Management | 2.3k | $0 | 5% | Dec 2023 |
|
| Bank of America Corporation | 1.1k | $19k | 96% | Dec 2023 |
|
| GAMMA Investing | 876.00 | $19k | -5% | Mar 2024 |
|
| ADAR1 Capital Management | 190.00 | $3.3k | 100% | Dec 2023 |
|
| Steward Partners Investment Advisory | 100.00 | $1.7k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 5.00 | $86.000000 | 0% | Dec 2023 |
|
Who sold out of Silence Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Sep 2023 | 267k | $2.6M |
| Deutsche Bank Aktiengesellschaft | Sep 2023 | 620.00 | $6.1k |